Brief: Sedana Medical Q2 Sales SEK 49.1 Million
17/07/2026 06:01
BRIEF-Sedana Medical Q2 Sales SEK 49.1 Million Jul 17 (Reuters) - Sedana Medical Q2 EBITDA SEK -1.9 million.
- Q2 net income SEK -9.6 million
- Q2 adjusted EPS SEK -0.1
- Q2 cash flow from operating activities SEK -7.7 million
- Q2 EBIT margin -19%
Recent news on Sedana Medical AB (publ)
See all newsSweden's Sedana Medical Q3 sales rise as growth returns
Brief: Sedana Medical Announces PDUFA Target Action Date
Brief: Sedana Medical Announces FDA Acceptance For Review Of Its New Drug Application In U.S.
Sweden's Sedana Medical Q2 sales flat, EBITDA loss narrows
Brief: Sedana Medical Q2 EBITDA Loss Narrows To SEK 1.9 Mln